Close
Nordic 9Nordic 9

V-Bio Ventures (investor - Venture Capital)

Belgium v-bio.ventures
See something wrong or missing? Let us know
Offices:Gent
Average round investment:38.03M USD
Average number per year:2.8
Distribution: 2025 (4)2024 (5)2023 (2)2022 (4)2021 (3) See the entire list
Portfolio companies: France Step PharmaUnited Kingdom RootWaveNetherlands Avidicure See the entire list
Mostly invests in: Belgium Belgium (15) Biotech (21)
See the entire list

Showing 3 of 25 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

V-Bio Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to V-Bio Ventures

Name Criteria
Switzerland Novartis Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands, United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
United States Pfizer Venture Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, United Kingdom
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Germany SevenVentures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing, Agriculture, Food Industry
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
Sweden HealthCap
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, Denmark
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Germany Yabeo
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Agriculture, Energy
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Italy
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, United Kingdom, Denmark
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Luxembourg Vesalius Biocapital Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium, France, Netherlands
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Switzerland ABB Technology Ventures (ATV)
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Energy, Robotics
  • Similar business models: B2B
  • Common investees countries: Netherlands, United Kingdom, Denmark
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Netherlands Icos Capital Management
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Pharma, Manufacturing, Agriculture, Food Industry, Energy
  • Similar business models: B2B
  • Common investees countries: France, Netherlands, United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
France Amundi Asset Management
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Agriculture, Food Industry, Energy
  • Similar business models: B2B
  • Common investees countries: France, United Kingdom, Italy
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Top